The Veterinary Oncology Market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 29.02 billion in 2033, at a CAGR of 9.8%. The market for veterinary oncology isn developing quickly as more people become aware that cancer is a serious pet health concern. Cancer is a leading cause of pet death, with about 1 in 4 dogs and 1 in 5 cats receiving a diagnosis at some point in their lives, according to the American Veterinary Medical Association (AVMA).
The global Veterinary Oncology market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector. The global Veterinary Oncology market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers & acquisitions, new product launches, and joint ventures.
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
The leading market contenders listed in the report are:
PetCure Oncology, Zoetis, Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd.
Research Report on the Veterinary Oncology Market Addresses the Following Key Questions:
Who are the dominant players of the Veterinary Oncology market?
Which regional market is anticipated to have a high growth rate over the projected period?
What consumer trends and demands are expected to influence the operations of the market players in the Veterinary Oncology market?
What are the key growth drivers and restraining factors of the Veterinary Oncology market?
What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
What is the overall impact of the COVID-19 pandemic on the Veterinary Oncology market and its key segments?
Emergen Research has segmented the global Veterinary Oncology market on the basis of type, type of care, and region
Segments Covered in this report are:
Animal Type Outlook (Revenue, USD Million; 2020-2033)
Canine
Feline
Equine
Therapy Outlook (Revenue, USD Million; 2020-2033)
Radiotherapy
Surgery
Chemotherapy
Immunotherapy
Other Therapies
Cancer Type Outlook (Revenue, USD Million; 2020-2033)
Skin Cancers
Lymphomas
Sarcomas
Others
In conclusion, the Veterinary Oncology Market report is an exhaustive database that will help readers formulate lucrative strategies. The Veterinary Oncology Market report studies the latest economic scenario with value, drivers, constraints, growth opportunities, challenges, demand and supply ratio, production capacity, import/export status, growth rate, and others. Additionally, the report also undertakes SWOT Analysis and Porter’s Five Forces Analysis to study the leading companies.
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.